Nicolas Hubacz: Immune Cells in the Embryo
Nicolas Hubacz, Advisory Board Member at Drug Target Review, Founder of NH Sponsorships, Biotech Club Mentor at UT Southwestern Medical Center, Clinical Products US West Business Development Manager at Magstim, shared a post on LinkedIn about a recent article by Hoang Anh Le et al. published in Nature Cell Biology, adding:
“Immune Cells in the Embryo
In this video, you’re seeing embryonic myeloid cells (red), among the earliest immune cells to emerge during development, spreading across developing frog tissue (blue).
New research shows that these cells aren’t navigating alone. The physical movement of surrounding tissue helps guide their migration.
As embryonic tissue spreads outward, early immune cells move along with it.
But they aren’t simply being carried by the flow. The cells reorganize their internal cytoskeleton and extend protrusions in the direction of tissue movement, allowing them to actively migrate with it.
This suggests that mechanical forces generated during development can provide directional cues to immune cells, helping them disperse throughout the embryo and establish an early line of defense.
Understanding how tissue movement guides immune cells could also reveal mechanisms involved in wound healing, inflammation, and cancer.
Video from work by Hoang Anh Le and colleagues, Department of Cell and Developmental Biology, University College London.
Research published in Nature Cell Biology, September 2026.”
Title: Tissue flow acts as a guidance cue for immune cell polarization and directional migration
Authors: Hoang Anh Le, Jonas Hartmann, Ricard Alert, Roberto Mayor

Other posts featuring Nicolas Hubacz on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support